Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) FCF Margin (2021 - 2023)

Senti Biosciences (SNTI) has 3 years of FCF Margin data on record, last reported at 5727.33% in Q4 2023.

  • For Q4 2023, FCF Margin rose 3545445.0% year-over-year to 5727.33%; the TTM value through Sep 2024 reached 14108.11%, up 1676212.0%, while the annual FY2023 figure was 3257.48%, 147797.0% down from the prior year.
  • FCF Margin reached 5727.33% in Q4 2023 per SNTI's latest filing, up from 1540.24% in the prior quarter.
  • Across five years, FCF Margin topped out at 5727.33% in Q4 2023 and bottomed at 29727.12% in Q4 2022.
  • Average FCF Margin over 3 years is 3258.46%, with a median of 1530.23% recorded in 2022.
  • Peak YoY movement for FCF Margin: tumbled -2922097bps in 2022, then soared 3545445bps in 2023.
  • A 3-year view of FCF Margin shows it stood at 506.14% in 2021, then tumbled by -5773bps to 29727.12% in 2022, then soared by 119bps to 5727.33% in 2023.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 5727.33% in Q4 2023, 1540.24% in Q3 2023, and 2037.67% in Q2 2023.